A large Swedish randomized trial (SCREESCO), published in Nature Medicine, evaluated over 278,000 60-year-olds assigned to: Unlike most prior trials,…
Browsing: Clinical Updates
The third week of February brings a wide-ranging set of updates across GI oncology, reflecting continued progress in both biological…
The FORTE trial is a large randomized clinical study evaluating whether patients with 1–2 non-advanced adenomatous polyps benefit from earlier…
Multi-cancer early detection (MCED) blood tests continue to face clinical validation challenges after Grail’s Galleri test failed to meet its…
Stool-based screening remains a cornerstone of colorectal cancer prevention, with randomized trials showing that screening can reduce CRC incidence by…
New research presented at the 2026 Crohn’s & Colitis Congress® highlights a rapidly evolving therapeutic landscape in inflammatory bowel disease…
For years, gut health has been used liberally across research papers, probiotic marketing campaigns, and patient conversations—often without a consistent…
Despite the introduction of more specific ICD-10-CM codes for short bowel syndrome (SBS), new real-world U.S. claims data presented at…
The American Gastroenterological Association (AGA) has released updated practice guidance on Barrett’s esophagus (BE) surveillance, marking its first comprehensive update…
As most colorectal cancers (CRC) originate from precancerous adenomas, the ability to detect these lesions early remains central to reducing…